Medical News

RSS

Robot-assisted surgery effective for five-year prostate cancer control: Study

A first-ever, long-term study of patients who underwent robot-assisted surgery to remove their cancerous prostates found that nearly 87 percent of them had no recurrence of the disease after five years.

19 Oct 2010

Transcept announces Intermezzo tablet preliminary data for insomnia

Transcept Pharmaceuticals, Inc. today announced its preliminary analysis of data from the recently completed Intermezzo 3.5 mg (zolpidem tartrate sublingual tablet) highway driving study.

19 Oct 2010

Dopamine behind mens susceptibility to alcoholism

Alcohol is one of the most commonly abused substances, and men are up to twice as likely to develop alcoholism as women. Until now, the underlying biology contributing to this difference in vulnerability has remained unclear.

19 Oct 2010

Salix presents two Phase 3 pivotal clinical trials data for non-C IBS at ACG Meeting

Salix Pharmaceuticals, Ltd. today announced the presentation of two analyses of data from its Phase 3 pivotal clinical trials, TARGET 1 and 2, demonstrating a 14-day course of XIFAXAN 550 mg (rifaximin) taken three times daily achieved adequate relief of symptoms of non-constipation irritable bowel syndrome (non-C IBS) in a significantly greater proportion of patients compared with placebo.

19 Oct 2010

NCCN updates Clinical Practice Guidelines for Breast Cancer

The National Comprehensive Cancer Network® (NCCN®) recently updated the NCCN Clinical Practice Guidelines for Oncology (NCCN Guidelines™) for Breast Cancer to affirm the recommendation regarding the use of bevacizumab (Avastin®, Genentech/Roche) in the treatment of metastatic breast cancer.

19 Oct 2010

Researchers to test nanoparticle-based theranostics for pancreatic cancer treatment

Researchers from Rice University's Laboratory for Nanophotonics (LANP), the radiology department at Baylor College of Medicine (BCM) and the University of Texas MD Anderson Cancer Center are preparing to test a combined approach for diagnosing and treating pancreatic cancer with a specially engineered nanoparticle.

19 Oct 2010

Karmanos Cancer Institute awarded $3M NIH grant to study triple-negative breast cancer

Scientists at the Barbara Ann Karmanos Cancer Institute in Detroit have received a nearly $3 million, five-year research project (RO1) grant from the National Institutes of Health to study a potentially ground-breaking immunotherapy treatment for women with one of the deadliest forms of breast cancer – triple-negative breast cancer. The research is exclusive to the Karmanos Cancer Institute.

19 Oct 2010

International investors take interest in Australia's biotechnology industry at ALSIS 2010

AusBiotech has kicked off its annual conference with a hugely successful Australasian Life Sciences Investment Summit 2010 in Melbourne today. The premier life science investment conference for Australia and the Asia-Pacific region attracted 150 investors from more than 100 organisations to hear 39 selected Australian biotechnology companies.

19 Oct 2010

Study observes interaction between HLA-C and ERAP1 genes in psoriasis

Genetic variants associated with increased susceptibility to psoriasis are reported in five papers published online this week in Nature Genetics. Psoriasis is a chronic and recurrent skin disease, and one of the most prevalent autoimmune diseases, with a global prevalence of 2-3%.

19 Oct 2010

Federal judge says he'll rule on Virginia's health law challenge by year's end

Bloomberg: "A federal judge in Virginia said he'll rule by yearend whether President Barack Obama's health care overhaul is constitutional, adding that his decision will be a 'brief stop' in the case on its way to the Supreme Court." U.S. District Court Judge Henry E. Hudson heard arguments today in Richmond, Virginia, about whether the health law's requirement for individuals to buy health insurance is congressional overreaching.

19 Oct 2010

Researchers report breakthrough studies in liver cell transplantation

Two research teams from the Okayama University Graduate School of Medicine (Okayama, Japan) have reported breakthrough studies in liver cell transplantation.

19 Oct 2010

Scientists complete genetic blueprints for 13 different strains of Lyme disease bacteria

Scientists supported by the National Institutes of Health (NIH) have determined the complete genetic blueprints for 13 different strains of Borrelia burgdorferi, the bacteria that cause Lyme disease. The achievement should lead to a better understanding of how genetic variations among strains may result in different courses of illness in people with Lyme disease, the most common tickborne disease in North America. The wealth of new genetic data will also help scientists develop improved ways to diagnose, treat and prevent Lyme disease.

19 Oct 2010

Study finds IAP enzyme maintains normal microbial population in gastrointestinal system

An enzyme that keeps intestinal bacteria out of the bloodstream may also play an important role in maintaining the normal microbial population of the gastrointestinal system.

19 Oct 2010

NeurogesX plans U.S. label expansion for Qutenza in HIV-associated neuropathy

NeurogesX, Inc., a biopharmaceutical company focused on developing and commercializing novel pain management therapies, today announced plans to pursue a U.S. label expansion for Qutenza® (capsaicin) 8% patch to include patients with painful HIV-associated neuropathy (HIV-AN, also referred to as HIV-distal sensory polyneuropathy (HIV-DSP)).

19 Oct 2010

Revised guidelines for first aid

The American Red Cross and American Heart Association today announced changes to guidelines for administering first aid. Among the revisions are updated recommendations for the treatment of snake bites, anaphylaxis (shock), jellyfish stings and severe bleeding. The First Aid Guidelines are being published in Circulation: Journal of the American Heart Association.

19 Oct 2010

Study quantifies impact of screening programs in pre-Medicare population

Investment in screening programs that target the pre-Medicare population, individuals aged between 50 and 64, is needed to reduce the costs of colorectal cancer in the Medicare program, according to the results of a new study, "Cost-Savings to Medicare from Increased Colorectal Cancer Screening in the Pre-Medicare Population," unveiled today at the American College of Gastroenterology's (ACG) 75th Annual Scientific meeting in San Antonio, Texas.

19 Oct 2010

Federal court to allow Calif. case on Medicare underpayments to move forward; LA county gets new health department head

A recent court decision gave a group of California counties another chance to challenge what they contend are severe Medicare underpayments that jeopardize access to care across the country.

19 Oct 2010

Novel bioelectric signals can cause stem cells to trigger melanoma-like growth in pigment cells

Biologists at Tufts University School of Arts and Sciences have discovered that a change in membrane voltage in newly identified "instructor cells" can cause stem cells' descendants to trigger melanoma-like growth in pigment cells. The Tufts team also found that this metastatic transformation is due to changes in serotonin transport. The discovery could aid in the prevention and treatment of diseases like cancer and vitiligo as well as birth defects.

19 Oct 2010

ShangPharma prices initial public offering of American depositary shares

ShangPharma Corporation, a leading China-based pharmaceutical and biotechnology research and development outsourcing company, today announced that its initial public offering of American depositary shares ("ADSs") was priced at $15 per ADS.

19 Oct 2010

Majority of Americans with diabetic foot ulcer suffer from PAD

A new analysis published by THE SAGE GROUP, concludes that peripheral artery disease (PAD) afflicts 2.0-3.7 million U.S. citizens with diabetic foot ulcers (DFU). Approximately 1 million diabetic foot ulcer patients suffer from the most severe and deadly form of PAD, critical limb ischemia.

19 Oct 2010

Medical News

Robot-assisted surgery effective for five-year prostate cancer control: Study

Transcept announces Intermezzo tablet preliminary data for insomnia

Dopamine behind mens susceptibility to alcoholism

Salix presents two Phase 3 pivotal clinical trials data for non-C IBS at ACG Meeting

NCCN updates Clinical Practice Guidelines for Breast Cancer

Researchers to test nanoparticle-based theranostics for pancreatic cancer treatment

Karmanos Cancer Institute awarded $3M NIH grant to study triple-negative breast cancer

International investors take interest in Australia's biotechnology industry at ALSIS 2010

Study observes interaction between HLA-C and ERAP1 genes in psoriasis

Federal judge says he'll rule on Virginia's health law challenge by year's end

Researchers report breakthrough studies in liver cell transplantation

Scientists complete genetic blueprints for 13 different strains of Lyme disease bacteria

Study finds IAP enzyme maintains normal microbial population in gastrointestinal system

NeurogesX plans U.S. label expansion for Qutenza in HIV-associated neuropathy

Revised guidelines for first aid

Study quantifies impact of screening programs in pre-Medicare population

Federal court to allow Calif. case on Medicare underpayments to move forward; LA county gets new health department head

Novel bioelectric signals can cause stem cells to trigger melanoma-like growth in pigment cells

ShangPharma prices initial public offering of American depositary shares

Majority of Americans with diabetic foot ulcer suffer from PAD

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News